Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials.
Valle, Juan W Furuse, J Jitlal, M Beare, S Mizuno, N Wasan, H Bridgewater, J Okusaka, T
Valle, Juan W
Furuse, J
Jitlal, M
Beare, S
Mizuno, N
Wasan, H
Bridgewater, J
Okusaka, T
Citations
Altmetric:
Abstract
Two recent studies (ABC-02 [UK] and BT22 [Japan]) have demonstrated the superiority of cisplatin and gemcitabine (CisGem) chemotherapy over gemcitabine (Gem) alone for patients with pathologically proven advanced biliary tract cancer (BTC: cholangiocarcinoma, gallbladder and ampullary cancers). This pre-planned analysis evaluates the efficacy of CisGem with increased statistical power.
Affiliation
Description
Date
2013-12-18
Publisher
Collections
Keywords
Type
Article
Citation
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. 2013: Ann Oncol